Mitral Atresia Overview

Save information for later
Sign Up

Learn About Mitral Atresia

What is the definition of Mitral Atresia?
Mitral valve atresia is a rare congenital (present at birth) defect of the heart’s mitral valve. The mitral valve connects the heart’s left atrium (upper chamber) and left ventricle (lower chamber). In mitral valve atresia blood from the left atrium does not flow to the left ventricle, causing the left ventricle to become underdeveloped, while the body's blood is not properly oxygenated. Mitral valve atresia is often associated with other congenital heart defects, such as transposition of the great arteries, patent ductus arteriosus, and coarctation of the aorta, among others.
What are the symptoms of Mitral Atresia?
Symptoms of mitral valve atresia depend on its severity and any associated congenital heart defects and may include difficulty breathing; rapid breathing; bluish or gray skin, lips, or nails (cyanosis); pale, cool, or clammy skin; poor peripheral pulses; rapid heart rate; failure to thrive; and congestive heart failure.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Mitral Atresia?
Treatment for mitral valve atresia may include oxygen, mechanical ventilation, diuretics, vasopressors, antibiotics, shunts, and staged corrective surgeries.
Who are the top Mitral Atresia Local Doctors?
Dr. Marc D. Knepp
Pediatric Cardiology | Cardiology | Pediatrics
Dr. Marc D. Knepp
Pediatric Cardiology | Cardiology | Pediatrics

Osf Multi-Specialty Group

420 Neglen Oak Ave, Suite 301, 
Peoria, IL 
 (203.5 mi)
309-655-3453
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Marc Knepp is a Pediatric Cardiologist and a Cardiologist in Peoria, Illinois. Dr. Knepp and is rated as an Experienced provider by MediFind in the treatment of Mitral Atresia. His top areas of expertise are Isthmian Coarctation, Coarctation of the Aorta, Ventricular Septal Defects, and Tetralogy of Fallot. Dr. Knepp is currently accepting new patients.

Dr. Michael G. Earing
Pediatric Cardiology | Cardiology | Pediatrics
Dr. Michael G. Earing
Pediatric Cardiology | Cardiology | Pediatrics

Advocate Health And Hospitals Corporation

4440 W 95th St, 
Oak Lawn, IL 
 (286.4 mi)
708-684-4393
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michael Earing is a Pediatric Cardiologist and a Cardiologist in Oak Lawn, Illinois. Dr. Earing and is rated as an Experienced provider by MediFind in the treatment of Mitral Atresia. His top areas of expertise are Congenital Heart Disease (CHD), Tetralogy of Fallot, Arachnodactyly, Marfan Syndrome, and Heart Transplant. Dr. Earing is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Dr. Raid Abdulla
Pediatric Cardiology | Pediatrics | Cardiology
Dr. Raid Abdulla
Pediatric Cardiology | Pediatrics | Cardiology
1653 W Congress Pkwy, 770 Jones, 
Chicago, IL 
 (297.4 mi)
312-942-6800
Languages Spoken:
English
See accepted insurances

Raid Abdulla is a Pediatric Cardiologist and a Pediatrics provider in Chicago, Illinois. Dr. Abdulla and is rated as an Experienced provider by MediFind in the treatment of Mitral Atresia. His top areas of expertise are Congenital Athymia, Hypoplastic Left Heart Syndrome (HLHS), Congenital Coronary Artery Malformation, and Atrioventricular Septal Defect.

View All Doctors
What are the latest Mitral Atresia Clinical Trials?
Prospective, Open-labeled, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of the Second-generation Tissue Engineered Vascular Graft as Vascular Conduits for Extracardiac Total Cavopulmonary Connection.
Prospective, Open-labeled, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of the Second-generation Tissue Engineered Vascular Graft as Vascular Conduits for Extracardiac Total Cavopulmonary Connection.
Who is this study for: Patients with Hypoplastic Left Heart Syndrome, Congential Heart Defects
Enrollment Status: Recruiting
Publish Date: May 06, 2024
Intervention Type: Combination product
Study Drug: Tissue Engineered Vascular Grafts
Study Phase: Phase 2

Summary: A single arm clinical trial evaluating the safety and efficacy of the second generation TEVG as vascular conduits for extracardiac total cavopulmonary connection.

Match to trials
Find the right clinical trials for you in under a minute
Get started
View All Clinical Trials